Tamsulosin Hydrochloride 0.4 mg + Deflazacort 30 mg (Tablet-in-Capsule) Tab-in-Cap (Trutam-Plus Tab-in-Cap)
Tamsulosin HCl 0.4 mg + Deflazacort 30 mg — Tablet-in-Capsule Technology
| Composition | Tamsulosin HCl 0.4 mg + Deflazacort 30 mg (Tablet-in-Capsule) |
|---|---|
| Dosage Form | Tab-in-Cap |
| Pack Type | Alu-Alu Blister |
| Pack Size | 10 x 10 Capsules |
| MRP | ₹ 6900 |
| Therapy | Urology — Alpha-1A blocker + corticosteroid combination |
| Storage | Store below 30 °C in a dry place, protected from light and moisture. |
WhatsApp EnquiryCall: +919041677932
For chemists, distributors and doctors: Trutam-Plus Tab-in-Cap (tamsulosin hydrochloride 0.4 mg + deflazacort 30 mg (tablet-in-capsule) tab-in-cap) is available from Trumac Healthcare on a PCD franchise with monopoly rights for your district, and as wholesale stock for licensed distributors. No franchise fee; first order from ₹25,000 – work out your margin with the PTR / PTS calculator.
See the full urology range – manufacturer, supplier and PCD franchise: BPH, overactive bladder, kidney-stone, UTI support and men’s-health tablets.
About Trutam-Plus Tab-in-Cap
Trutam-Plus is a novel tablet-in-capsule technology delivering Tamsulosin HCl 0.4 mg (modified-release tablet) along with Deflazacort 30 mg inside a single capsule shell. The combination supports medical expulsive therapy of lower-ureteric stones with inflammatory oedema.
Tamsulosin relaxes the smooth muscle of the distal ureter, bladder neck and prostatic urethra; Deflazacort, an oxazoline derivative of prednisolone, reduces local ureteric inflammatory oedema that obstructs stone passage.
Trumac Healthcare supplies Trutam-Plus, made at WHO-GMP certified partner units, for PCD pharma franchise across India.
Trutam-Plus Tab-in-Cap का उपयोग (हिंदी में): प्रोस्टेट (पेशाब की रुकावट) की दवा। सभी Trumac दवाओं के उपयोग हिंदी और अंग्रेज़ी में – Trumac Healthcare tablet uses A–Z। दवा हमेशा डॉक्टर की सलाह से ही लें।
Watch: Trutam-Plus Capsules – product video (pack and composition). For PCD franchise rates, use the WhatsApp button on this page.
Indications
- Medical expulsive therapy for lower-ureteric stones (5–10 mm) with mucosal oedema
- Symptomatic relief in benign prostatic hyperplasia with inflammatory component
- Post-stenting ureteric symptoms (specialist use)
Mechanism of Action
Tamsulosin selectively blocks alpha-1A adrenoceptors which dominate in the prostate, bladder neck and distal ureter — relaxing smooth muscle and easing voiding. Deflazacort is a glucocorticoid prodrug converted to its active 21-OH metabolite; it suppresses phospholipase A2, reducing prostaglandin and leukotriene production and shrinking oedema around the impacted stone — improving stone passage rates in MET.
Dosage & Administration
- Adults: 1 capsule once daily, 30 minutes after the same meal each day
- Continue for 4 weeks or until stone expulsion
- Swallow whole — do not crush or chew
- Use under urologist supervision
Side Effects
- Postural hypotension and dizziness
- Ejaculatory dysfunction
- Fluid retention
- Increased appetite
- Mood changes (with steroid component)
- Hyperglycaemia in diabetics
Contraindications & Precautions
- Hypersensitivity to tamsulosin or deflazacort
- History of orthostatic hypotension
- Severe hepatic impairment
- Untreated active infection
- Live vaccines during treatment
Storage
Store below 30 °C in a dry place, protected from light and moisture.
From Trumac Healthcare, a pharma franchise company in India, available on a monopoly basis – see the urology products range product list (PDF). See our full PCD franchise capsules range. Comparing companies? See the urology PCD companies compared. No franchise fee; minimum first order ₹25,000 – cost and documents.
Trutam-Plus Tab-in-Cap is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
q
a
q
a
q
a
q
a
q
a
Related Products
